231 related articles for article (PubMed ID: 25557434)
1. Tumor thickness as a prognostic factor in extramammary Paget's disease.
Ito T; Kaku Y; Nagae K; Nakano-Nakamura M; Nakahara T; Oda Y; Hagihara A; Furue M; Uchi H
J Dermatol; 2015 Mar; 42(3):269-75. PubMed ID: 25557434
[TBL] [Abstract][Full Text] [Related]
2. Prognostic indicators in 35 patients with extramammary Paget's disease.
Ito Y; Igawa S; Ohishi Y; Uehara J; Yamamoto AI; Iizuka H
Dermatol Surg; 2012 Dec; 38(12):1938-44. PubMed ID: 22989161
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of sentinel lymph node biopsy for the detection of metastasis in the early stage of extramammary Paget's disease.
Kusatake K; Harada Y; Mizumoto K; Kaneko S; Niihara H; Chinuki Y; Morita E
Eur J Dermatol; 2015 Apr; 25(2):156-61. PubMed ID: 26075323
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of sentinel lymph node biopsy for prognostic prediction in extramammary Paget's disease.
Ogata D; Kiyohara Y; Yoshikawa S; Tsuchida T
Eur J Dermatol; 2016 Jun; 26(3):254-9. PubMed ID: 26985569
[TBL] [Abstract][Full Text] [Related]
5. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget's disease: Multi-center, retrospective study of 151 patients.
Fujisawa Y; Yoshino K; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Fujimoto M; Ohara K
J Dermatol Sci; 2015 Jul; 79(1):38-42. PubMed ID: 25944505
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.
Tsutsui K; Takahashi A; Muto Y; Mizuta H; Jinnai S; Nakama K; Ogata D; Namikawa K; Yamazaki N
J Dermatol; 2020 May; 47(5):512-517. PubMed ID: 32157716
[TBL] [Abstract][Full Text] [Related]
7. Primary invasive carcinoma associated with penoscrotal extramammary Paget's disease: a clinicopathological analysis of 56 cases.
Dai B; Kong YY; Chang K; Qu YY; Ye DW; Zhang SL; Zhang HL
BJU Int; 2015 Jan; 115(1):153-60. PubMed ID: 24731175
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors of Extramammary Paget's Disease.
Hatta N
Curr Treat Options Oncol; 2018 Aug; 19(10):47. PubMed ID: 30112691
[TBL] [Abstract][Full Text] [Related]
9. Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients.
Hatta N; Yamada M; Hirano T; Fujimoto A; Morita R
Br J Dermatol; 2008 Feb; 158(2):313-8. PubMed ID: 18028492
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in patients with extramammary Paget's disease.
Hatta N; Morita R; Yamada M; Echigo T; Hirano T; Takehara K; Ichiyanagi K; Yokoyama K
Dermatol Surg; 2004 Oct; 30(10):1329-34. PubMed ID: 15458530
[TBL] [Abstract][Full Text] [Related]
11. Primary invasive extramammary Paget disease on penoscrotum: a clinicopathological analysis of 41 cases.
Shu B; Shen XX; Chen P; Fang XZ; Guo YL; Kong YY
Hum Pathol; 2016 Jan; 47(1):70-7. PubMed ID: 26508372
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy for lymph node metastasis from extramammary Paget's disease.
Hata M; Koike I; Wada H; Minagawa Y; Kasuya T; Matsui T; Suzuki R; Takano S; Inoue T
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):873-7. PubMed ID: 23663098
[TBL] [Abstract][Full Text] [Related]
13. The expression of HER-2 in extramammary Paget's disease.
Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H
Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR
Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
[TBL] [Abstract][Full Text] [Related]
16. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
Hirai I; Funakoshi T
J Dermatol; 2017 Oct; 44(10):1148-1151. PubMed ID: 28406527
[TBL] [Abstract][Full Text] [Related]
17. Extramammary Paget's disease of the unilateral axilla: a review of seven cases in a 20-year experience.
Chiu CS; Yang CH; Chen CH
Int J Dermatol; 2011 Feb; 50(2):157-60. PubMed ID: 21244378
[TBL] [Abstract][Full Text] [Related]
18. Indications for lymph node dissection in the treatment of extramammary Paget's disease.
Tsutsumida A; Yamamoto Y; Minakawa H; Yoshida T; Kokubu I; Sugihara T
Dermatol Surg; 2003 Jan; 29(1):21-4. PubMed ID: 12534507
[TBL] [Abstract][Full Text] [Related]
19. Extramammary Paget's disease: extended subclinical growth detected using three-dimensional histology in routine paraffin procedure and course of the disease.
Boehringer A; Leiter U; Metzler G; Moehrle M; Garbe C; Breuninger H
Dermatol Surg; 2011 Oct; 37(10):1417-26. PubMed ID: 21767327
[TBL] [Abstract][Full Text] [Related]
20. Extramammary Paget's disease of the axilla: an unusual case.
Chagpar AB; Heim K; Carron KR; Sewell C
Breast J; 2007; 13(3):291-3. PubMed ID: 17461905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
